Stockreport

Arbutus to launch mid-stage study of HBV triplet therapy in coming weeks [Seeking Alpha]

Arbutus Biopharma Corporation  (ABUS) 
Last arbutus biopharma corporation earnings: 11/6 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.arbutusbio.com/node/5806
PDF Arbutus to launch mid-stage study of HBV triplet therapy in coming weeksArbutus Biopharma (NASDAQ:ABUS)announces 2018 expected milestones:Q1: Commence Phase 2 study of A [Read more]